Article
Impact of PTEN abnormalities on outcome in pediatric patients with T-cell acute lymphoblastic leukemia treated on the MRC UKALL2003 trial.
Leukemia - 1 Jan 2016
Jenkinson S, Kirkwood A A, Goulden N, Vora A, Linch D C, Gale R E
Abstract excerpt
PTEN gene inactivation by mutation or deletion is common in pediatric T-cell acute lymphoblastic leukemia (T-ALL), but the impact on outcome is unclear, particularly in patients with NOTCH1/FBXW7 mutations. We screened samples from 145 patients treated on the MRC UKALL2003 trial for PTEN mutations using heteroduplex analysis and gene deletions using single nucleotide polymorphism arrays, and related genotype to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
